For years, regional health plans benefited from powerful tailwinds: Medicare Advantage growth, Medicaid expansion, and a prospering ACA marketplace. But many of those growth engines have stalled, just as new pressures emerged: rising utilization, runaway spend, pricing uncertainty and more scrutiny from patients and policy makers. The result is a dramatically different financial reality for health plans. In 2024, only eight of 33 Blues plans reported positive operating margins.

In this episode, host Rae Woods sits down with Jared Landis, Vice President of Advisory Board's Health Plan Research practice, to unpack how regional plans got here and the three-year turnaround strategy regional and Blues plans are now pursuing.

Together, they explore the market forces that upended the payer playbook, the operational and pricing changes plans are making to stabilize performance, and how AI-enabled transformation could reshape the future of the insurance business.

Stay tuned to the end of the episode for an update on the Rural Health Transformation Program, including a key deadline this fall.

We’re here to help:

Sponsor link: Precision in motion: How digital tools support diabetes care providers

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, Abby Burns welcomes back Megan Zweig, CEO of Rock Health Advisory, to answer audience questions submitted during Advisory Board's Research Summit in Carlsbad, California.

Together, they explore how health systems are engaging with the explosion in consumer-generated data, the role of medtech and pharma in AI-enabled innovation, and why AI enablement may be able to unlock personalized care for a wider range of patients.

We’re here to help:

Rock Health

• H1 2026 funding and market overview: Durable roots, shifting routes | Rock Health

Want to see a live recording of Radio Advisory? Register for an Advisory Board summit and get the insights your organization needs to navigate uncertainty and build lasting resilience.

Advisory Board members: Action requested! Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

Nearly 70% of adults ages 65 and over skipped the latest COVID vaccine. Learn how health systems can treat vaccine uncertainty as a routine care gap — not patient resistance — by reading Advisory Board’s expert insight.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Oncology is simultaneously one of healthcare's greatest success stories and one of its biggest financial challenges. Cancer care continues to benefit from breakthroughs in precision medicine and early detection, even as oncology spending is projected to approach $200 billion by 2029. At the same time, cancer programs are facing rising patient volumes, growing demand for advanced therapies, and mounting pressure to improve access and affordability.

In this episode, hosts Abby Burns and Chloe Bakst welcome oncology expert Gaby Marmolejos to break down the trends shaping cancer care in 2026 and beyond. Together, they explore improvements in community-based access to advanced therapies, the promise of multi-cancer early detection testing, and the reimbursement challenges threatening program sustainability.

We’re here to help:

Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Value-based care is entering its accountability era. Participation in value-based arrangements continues to grow, even as financial pressures weigh down on both providers and payers. But CMMI is setting a clear tone about what it expects from stakeholders moving forward: results.

Host Abby Burns sits down with Advisory Board experts Clare Wirth, Payton Grimes, and Rhea Jain to explore what’s changed — and what hasn’t — in value-based care. From Medicare Advantage turbulence to the push for specialist engagement and greater downside risk, the group breaks down what leaders need to know about how the value-based care landscape is evolving.

We’re here to help:

Help shape Advisory Board’s next research agenda by taking our quick survey — share your priorities and challenges to ensure our research reflects what matters most to healthcare leaders like you.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

After years of uncertainty, many healthcare executives say they’ve experienced more change in the past five years than in their entire careers. Policy shifts, evolving patient expectations, and rapid advances in AI are all colliding at once — forcing leaders to rethink how they operate and where they invest.

But here’s the surprising part: the overwhelming sentiment isn’t panic. It’s clarity.

In this episode, host Rachel (Rae) Woods sits down with Advisory Board researchers Morghen Philippi and Marisa Nives to share what they’re hearing from months of research conversations with leaders across the ecosystem. Together, they offer a grounded look at how peers, partners, and competitors are thinking right now — where leaders are aligned, where they’re making different bets, and what they’re prioritizing next.

We’re here to help:

Q&A with a clinical pharmacist: Reimagining diabetes care

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Digital health funding is heating up—but where are the dollars going? And what does it mean for health systems’ digital health strategies?

In this live episode, recorded at Advisory Board’s Research Summit, host Abby Burns sits down with Megan Zweig, President and CEO of Rock Health Advisory, for an update on what’s going on in the world of digital health funding. Together, they unpack what investment activity looks like and explore questions around what constitutes an investable thesis in 2026, how health systems are—or could be—engaging in the startup ecosystem, and what it takes to be a good incubation partner.

We’re here to help:

The role of pharmacists in cardiometabolic care

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

As health systems anticipate greater downward pressures on margins in the months and years to come, they’re homing their growth strategies accordingly. As we’ve been saying in our research the past couple of years, “sustainability” is now the name of the game. Here’s the conundrum: our research also shows that 90% of systems are betting on the same growth plays as their competition. And more and more, those bets converge on a common goal: win more commercial volumes.

In this episode, host Abby Burns sits down with Advisory Board experts Shay Pratt and Emily Heuser to unpack the three main avenues health systems are exploring to win commercial volumes: ambulatory care, service lines, and direct-to-employer contracting. For each, they explore a “hard truth” and corresponding mindset shift leaders must face as they weigh what it will take to generate margin-accretive growth.

We’re here to help:

Learn more about Advisory Board’s 2026 summit series.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

CMS continues to pull on the levers it has at its disposal to rein in national healthcare spend, including rulemaking around Medicare Advantage. In April, CMS announced the final rate for MA plans for CY2027, after a controversial proposed rule generated animated pushback — and a fair bit of panic — among payers.

In this episode, host Abby Burns speaks with Alex Balmes, Vice President of Actuarial Services at Optum, to unpack what did — and didn’t — end up in the final rate announcement, and what that signals for the future of the Medicare Advantage program. Together, they explore the components of the final rate that are most important for payers and providers to pay attention to, respectively, and why.

Also in the 2027 final announcement, but not discussed in this episode: four measures are being added or updated in Star ratings calculations (Colorectal Cancer Screening; Care for Older Adults – Functional Status Assessment; Concurrent Use of Opioids and Benzodiazepines (COB); Polypharmacy: Use of Multiple Anticholinergic Medications in Older Adults (Poly-ACH)) and three are being removed (Care for Older Adults – Pain Assessment, Medication Reconciliation Post-Discharge, Medication Therapy Management (MTM) Program Completion Rate for Comprehensive Medication Review (CMR))

We’re here to help:

Learn more about Advisory Board’s 2026 summit series.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Maternity care touches nearly every corner of the U.S. health system. About 25% of all hospitalizations involve a mother or newborn, and maternity spending accounts for roughly 0.8% of U.S. GDP — making it one of the most economically significant service lines in health care. Against that backdrop, a little noticed decision to unbundle maternity billing codes represents a generational shift in how pregnancy, delivery, and postpartum care are paid for.

In this episode of Radio Advisory, host Rae Woods sits down with Neel Shah, MD, Chief Medical Officer at Maven Clinic, to break down what the new maternity billing codes mean for providers, health plans, and patients. Together, they explore why the old bundle broke down, how unbundling could reshape care delivery, and what health leaders should be doing now as 2027 approaches.

We’re here to help:

Learn more about Advisory Board’s 2026 summit series.

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Health care leaders are navigating one of the most volatile policy environments in decades. The next major reform fight hasn’t arrived yet — but in its place, a steady wave of rulemaking, regulatory shifts, and enforcement actions is driving real change. Policies are evolving faster, reversing more often, and creating a level of uncertainty that makes even the most seasoned strategists question what to act on, what to wait out, and what to ignore.

This moment of policy whiplash isn’t theoretical — it’s reshaping care delivery models, workforce strategy, and long term investment decisions across the industry.

In this live episode, recorded at Advisory Board’s Washington, D.C. Summit on May 4, 2026, host Rae Woods sits down with Julie Rovner — chief Washington correspondent at KFF Health News and host of the What the Health? podcast — to make sense of this “in between” moment of health policy.

Drawing on four decades of reporting across multiple administrations and reform cycles, Julie helps leaders separate meaningful signals from noise, understand where real policy power sits today, and anticipate what could define the next era of health reform.

We’re here to help:

4 ways health systems are reducing EVS costs while improving performance

A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.